Variation of serum erythropoietin ( EPO, a), soluble transferrin receptors ( sTfR, b) and ferritin ( Ferritin, c), after treatment by 250 mg (D250) or 500 mg (D500) of ACZ compared to CMS placebo-treated group (Placebo) and normal control subjects (Control). Data are mean SD. *, **, ***, P < 0.05, P < 0.01 and P < 0.001 after versus before treatment. #, ###, P < 0.05 and P < 0.001 versus Placebo.
Additional keywords: EPO,chronic mountain sickness,ferritin